Monday 06th of September 2010 06:15:38 PM
Home
About us
Technologies
Products
Clinical Trials
Collaborations
News & Events
Careers
Contact
Company profile
Team
Corporate Details
Overview
Human antibodies
Vascular targeting
Target discovery
Chemical Libraries
Easy Iodine
GMP
PIPELINE
L19-131I
L19-TNF
DARLEUKIN
TELEUKIN
TENARAD
TENAPET
DODECAL
DEKAVIL
ALBUFLUOR
VANGIOLUX
News
Conferences
Siena
Zurich
Adresses
Directions
Overview
L19-131I
L19-TNF
DARLEUKIN
TELEUKIN
TENARAD
DEKAVIL
Documento senza titolo
CONFERENCES
> 2010
> 2009
> 2008
> 2007
> 2006
> 2005
> 2004
> 2003
> 2002
> 2001
Conferences 2010
June 2010
M. Kaspar - "Phase I/II clinical trial results of tumor-targeting antibody-cytokine fusion proteins of the Philogen pipeline".
IBC's Next Generation Protein Therapeutics/Biologics Summit (San Francisco), 21-23 June 2010
Documento senza titolo
Disclaimer
Privacy
© 2009 Philogen S.p.A.